Clinical Trial Update: A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of Zasocitinib in children and teenagers with plaque psoriasis is currently recruiting. The sponsor is Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Zasocitinib (Zasocitinib)

Snippet

Sponsor: Takeda | Conditions: Plaque Psoriasis | Phase 3 | Status: RECRUITING